Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 6, Pages 1333-1340
Publisher
Wiley
Online
2012-08-13
DOI
10.1002/ijc.27768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase II trial of temsirolimus in patients with metastatic breast cancer
- (2012) Gini F. Fleming et al. BREAST CANCER RESEARCH AND TREATMENT
- A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
- (2012) C. Renner et al. HAEMATOLOGICA
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Full Functional-Length Urethral Sphincter Preservation During Radical Prostatectomy
- (2011) Thorsten Schlomm et al. EUROPEAN UROLOGY
- Current and future directions in mammalian target of rapamycin inhibitors development
- (2011) Angelica Fasolo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New phosphatidylinositol 3-kinase inhibitors for cancer
- (2011) Daniel W Bowles et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
- (2011) C. B. Boers-Doets et al. ONCOLOGIST
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
- (2010) S. Minner et al. CLINICAL CANCER RESEARCH
- Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): A tissue microarray study (TMA)
- (2010) Sevan Evren et al. PROSTATE
- High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
- (2010) Sarah Minner et al. PROSTATE
- Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics
- (2009) Bo Dai et al. BJU INTERNATIONAL
- TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
- (2009) J. Copp et al. CANCER RESEARCH
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
- (2009) Chunru Lin et al. CELL
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
- (2009) R.-S. Mani et al. SCIENCE
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
- (2008) Y Wang et al. ONCOGENE
- Aktive Überwachung des Prostatakarzinoms
- (2008) M. Graefen et al. UROLOGE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started